Following the Company's policy of establishing separate entities to commercialize sufficiently developed technologies addressing identifiable needs within particular communities, Endogenics, Inc. is CDR's first wholly owned subsidiary.

Endogenics' purpose is to commercially exploit CDR's cell modeling technologies in the bio-medical research and educational markets. For more information about this exciting new venture, please visit http://www.endogenics.com/